Skip to main content

Latest SEC Filings — Page 81

Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.

MetLife Investment Management Buys $11M of Calamos Global Dynamic Income Fund Preferred Shares
ProForm 4CHW · Form 4 · 2026-08-26
Veeva Beats Q2 Estimates, Raises Full-Year Guidance on AI Momentum
Form 8-KVEEV · Form 8-K · 2026-08-26
Everpure Q2 Revenue Jumps 38%, FY27 Guidance Raised Sharply
ProForm 8-KP · Form 8-K · 2026-08-26
Agilent Beats Q3, Raises FY26 Guidance on 8% Revenue Growth
Form 8-KA · Form 8-K · 2026-08-26
MetLife Investment Management Buys $22M of CCD Series I Preferred Shares After Series D Redemption
Form 4CCD · Form 4 · 2026-08-26
InterCure Finalizes $5M Private Placement at $2.918/Unit with CEO Participation Pending Approval
Form 6-KINCR · Form 6-K · 2026-08-26
CEO James Cacioppo Buys $342K of Jushi Stock at $0.48-$0.49
Form 4JUSH · Form 4 · 2026-08-26
Inhibikase Swaps Auditors, Dropping CohnReznick for Deloitte
ProForm 8-KIKT · Form 8-K · 2026-08-26
Mercury General Founder George Joseph Dies at 104; CEO Tirador Named Chairman
Form 8-KMCY · Form 8-K · 2026-08-26
MetLife Investment Management Swaps $11M of Redeemed Series D Preferred for $8.6M of Series H
Form 4CHI · Form 4 · 2026-08-26
Change Agents Seeks Approval for Up to $100M in Future Issuances and 25M New Authorized Shares
ProForm PRER14ACHGA · Form PRER14A · 2026-08-26
Getty Family and KED Form 13D Group Controlling 72.8% of Getty Images
Form SCHEDULE 13D/AGETY · Form SCHEDULE 13D/A · 2026-08-26
LeonaBio Reaches 500th Patient in Phase 3 ELAINE-3, Opening $146M Warrant Exercise Window
Form 8-KLONA · Form 8-K · 2026-08-26
CFO Sarah Romano Departs SS Innovations Just 18 Days After Starting
ProForm 8-KSSII · Form 8-K · 2026-08-26
MetLife Redeems $13M Series D Preferred, Buys $7.25M Series H
Form 4CHY · Form 4 · 2026-08-26
Salesforce Lifts FY27 Revenue Outlook to $46.1B-$46.4B After Blowout Quarter
ProForm 8-KCRM · Form 8-K · 2026-08-26
Zoom's Q2 Net Income Soars to $1.54B on $1.61B Anthropic Gain; EDNY Probe Still Open
Form 10-QZM · Form 10-Q · 2026-08-26
Okta Q2 FY27: Revenue Beats, cRPO Accelerates, Full-Year Guidance Raised
Form 8-KOKTA · Form 8-K · 2026-08-26
Gossamer Bio Formalizes $25M Series A-1 Preferred Stock with 4X Liquidation Preference and $0.14 Conversion Price
ProForm 8-KGOSS · Form 8-K · 2026-08-26
Yimutian to Issue 46.3B Shares for US$27M in Real Estate and Industrial Asset Acquisitions
ProForm 6-KYMT · Form 6-K · 2026-08-26
Nutanix Q4 Beats Across the Board: 16% ARR Growth, $840M FY26 Free Cash Flow, and FY27 Guidance Above Consensus
ProForm 8-KNTNX · Form 8-K · 2026-08-26
Cardiff Oncology Seeks Shareholder Approval to Nearly Double Authorized Shares to 320M
Form DEF 14ACRDF · Form DEF 14A · 2026-08-26
Great Elm Group Swings to $36.9M FY2026 Loss on Investment Write-Downs
Form 10-KGEG · Form 10-K · 2026-08-26
eSports Now Exchanges Pre-Funded Warrant for 833,334 Shares, Holds 9.9% Stake
Form SCHEDULE 13DSLE · Form SCHEDULE 13D · 2026-08-26
Copper Property Trust Sues Onyx for $150M Over Failed $947M Portfolio Sale
ProForm 8-KCPPTL · Form 8-K · 2026-08-26
Stockholders Back 100M Share Equity Plan Expansion and Written Consent Change
Form 8-KTVGN · Form 8-K · 2026-08-26
SU Group Quantifies Warrant Amendment: 42.7M Shares at $0.70, ~$29.9M Potential Proceeds
Form 424B3SUGP · Form 424B3 · 2026-08-26
QuinStreet FY2026: Revenue Climbs 18% to $1.29B, Net Income Swings to $81M on Tax Benefit
Form 10-KQNST · Form 10-K · 2026-08-26
Xiao-I Secures $4M Through Highly Dilutive Convertible Note with Variable Conversion Price
ProForm 424B5AIXI · Form 424B5 · 2026-08-26
SSEA Signs $200M Merger with SuperiorMed — Full Terms Disclosed
ProForm 425SSEA · Form 425 · 2026-08-26